| OrPha Swiss GmbH - Tadalafil PAH OrPha 20 mg, Filmtabletten | | 67968 | | 01 | | Tadalafil PAH OrPha 20 mg | | Filmtabletten | | G04BE08 | | Tadalafil | | 23.07.2020 | | |
| | Composition | | tadalafilum 20 mg, lactosum 312.5 mg, carmellosum natricum conexum, natrii laurilsulfas, hydroxypropylcellulosum, polysorbatum 80, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 2.8 mg, E 171, triacetinum, talcum, E 172 (flavum), pro compresso obducto corresp. natrium 1.91 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Tadalafilum | 20 mg |
| | BAG: Active Agent | Dose |
|---|
| Tadalafilum | 20 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactosum | 312.5 mg | | | Lactose Monohydrate | 2.8 mg | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Polysorbatum 80 | | | | Pro Compresso Obducto | | | | Talcum | | | | Triacetinum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 56 | 455.04 | 511.30 | B | SL | Yes |
|
|
